Zhejiang Lanyu Digital Technology
301585
BBK Test Systems
301598
MEIZHIGAO
834765
Youkeshu Technology
300209
Hangzhou Raycloud Technology Co.,Ltd
688365
CN Stock MarketDetailed Quotes
300683 Wuhan Hiteck Biological Pharma
- 25.72
- +0.19+0.74%
Market Closed Dec 20 15:00 CST
3.37BMarket Cap-25.09P/E (TTM)
25.98High25.38Low13.30KlotVolume25.50Open25.53Pre Close34.21MTurnover1.09%Turnover RatioLossP/E (Static)130.89MShares36.1952wk High1.38P/B3.14BFloat Cap18.8052wk Low30.64Limit Up122.06MShs Float84.84Historical High20.42Limit Down2.35%Amplitude18.80Historical Low--Dividend TTM25.73Avg Price6.13KlotAsk--Div YieldTTM100Lot Size7.01KlotBid
Wuhan Hiteck Biological Pharma Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -4.02%420.7M | -9.01%277.08M | -10.54%133.87M | -8.50%622.51M | -11.13%438.33M | -2.01%304.51M | -6.71%149.64M | 24.43%680.36M | 35.51%493.22M | 25.51%310.76M |
| Refunds of taxes and levies | -78.45%4.69M | -92.88%1.46M | -85.51%5.2K | 42.36%33.16M | 40.79%21.77M | 63.98%20.44M | 99.57%35.87K | 190.11%23.29M | 3,512.18%15.46M | 2,811.24%12.46M |
| Cash received relating to other operating activities | 237.01%96.89M | 450.54%93.57M | 492.65%55.94M | -17.05%26.27M | 6.49%28.75M | -7.91%17M | 32.76%9.44M | 14.51%31.67M | 9.67%27M | 15.60%18.46M |
| Cash inflows from operating activities | 6.84%522.28M | 8.82%372.1M | 19.29%189.81M | -7.26%681.93M | -8.74%488.85M | 0.08%341.94M | -5.02%159.11M | 26.24%735.32M | 37.70%535.68M | 29.43%341.68M |
| Goods services cash paid | -18.56%151.61M | -27.44%104.39M | -19.35%57.11M | -10.75%243.41M | -22.04%186.17M | -19.28%143.86M | -30.66%70.82M | 56.96%272.73M | 109.09%238.82M | 153.31%178.22M |
| Staff behalf paid | 14.57%214.7M | 19.19%151.79M | 25.26%88.8M | 20.82%252.54M | 26.60%187.39M | 27.21%127.36M | 25.53%70.89M | 20.84%209.03M | 17.01%148.02M | 6.67%100.11M |
| All taxes paid | -5.09%20.35M | -28.82%12.63M | -25.66%5.27M | -26.43%24.01M | -27.41%21.44M | 3.61%17.75M | -23.01%7.09M | 15.45%32.63M | 41.71%29.54M | -6.06%17.13M |
| Cash paid relating to other operating activities | -21.62%107.87M | -13.16%73.06M | -2.83%29.48M | -6.70%156.65M | 21.03%137.62M | 12.64%84.13M | -24.40%30.34M | -14.07%167.9M | -10.51%113.71M | -17.21%74.69M |
| Cash outflows from operating activities | -7.15%494.54M | -8.37%341.87M | 0.85%180.67M | -0.83%676.62M | 0.48%532.63M | 0.80%373.1M | -13.85%179.14M | 19.62%682.28M | 36.40%530.09M | 35.75%370.15M |
| Net cash flows from operating activities | 163.36%27.74M | 197.05%30.24M | 145.66%9.14M | -89.98%5.31M | -883.59%-43.78M | -9.44%-31.16M | 50.46%-20.03M | 338.72%53.03M | 1,321.14%5.59M | -228.35%-28.47M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -4.16%1.04B | -35.15%589.18M | -38.34%172.94M | -19.95%1.46B | 7.68%1.08B | 4.19%908.57M | 146.93%280.5M | 23.63%1.83B | 32.75%1.01B | 74.04%872.02M |
| Cash received from returns on investments | 43.35%13.95M | 3.21%6.6M | -78.38%470.9K | 27.78%19.43M | -27.80%9.73M | -42.26%6.39M | 13.64%2.18M | 0.34%15.21M | 59.57%13.48M | 53.44%11.07M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -99.27%15K | ---- | ---- | 9,147.11%2.07M | 13,419.83%2.07M | 1,630.53%261.31K | ---- | 16.72%22.38K | 1,810.00%15.28K | 2,920.00%15.1K |
| Net cash received from disposal of subsidiaries and other business units | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -29.93%3M | --2.55M | --2.55M |
| Cash inflows from investing activities | -3.92%1.05B | -34.90%595.78M | -38.65%173.42M | -19.57%1.48B | 7.14%1.09B | 3.34%915.23M | 144.72%282.68M | 23.24%1.85B | 33.38%1.02B | 74.25%885.66M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -69.83%29.46M | -57.54%23.94M | -67.09%16.87M | -3.75%167.44M | -28.07%97.65M | -40.06%56.4M | -9.13%51.26M | -29.60%173.97M | -27.72%135.76M | -10.68%94.1M |
| Cash paid to acquire investments | -28.81%1.05B | -49.71%719.03M | -64.21%207.82M | 60.97%1.81B | 109.01%1.47B | 241.92%1.43B | 432.12%580.73M | -43.99%1.12B | -22.18%705.45M | -35.93%418.2M |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | ---- | ---- | -68.81%7.09M | -77.21%7.09M | ---- | -88.47%22.72M | --22.72M | --31.11M |
| Cash paid relating to other investing activities | ---- | ---- | ---- | -33.33%126K | ---- | ---- | --71.25K | -4.55%189K | ---- | ---- |
| Cash outflows from investing activities | -31.66%1.08B | -50.25%742.97M | -64.45%224.68M | 49.66%1.98B | 82.80%1.58B | 174.82%1.49B | 281.81%632.06M | -46.11%1.32B | -21.06%863.93M | -28.32%543.4M |
| Net cash flows from investing activities | 94.28%-27.74M | 74.54%-147.2M | 85.33%-51.27M | -193.64%-491.93M | -407.94%-484.89M | -268.92%-578.16M | -598.31%-349.38M | 155.13%525.36M | 147.92%157.46M | 236.99%342.26M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | --290M | --290M | --290M | --290M | ---- | ---- | ---- |
| Cash from borrowing | ---- | ---- | ---- | --10M | --10M | ---- | ---- | ---- | ---- | ---- |
| Cash received relating to other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.73M | ---- |
| Cash inflows from financing activities | ---- | ---- | ---- | --300M | 17,239.11%300M | --290M | --290M | ---- | -99.73%1.73M | ---- |
| Borrowing repayment | -67.41%10.95M | -77.47%7.3M | 204.17%3.65M | 668.29%47.25M | 578.79%33.6M | 653.49%32.4M | -67.12%1.2M | 2.50%6.15M | -45.00%4.95M | -46.25%4.3M |
| Dividend interest payment | 138.74%1.39M | 66.92%974.2K | 55.69%507.94K | 64.33%2.2M | -34.66%583.63K | -65.53%583.63K | --326.25K | 2,059.88%1.34M | 246.60%893.27K | 5,104.35%1.69M |
| Cash payments relating to other financing activities | -2.24%2.81M | -64.98%1.01M | -63.95%640.18K | -52.92%2.26M | 55.59%2.88M | --2.88M | --1.78M | -20.83%4.8M | 208.33%1.85M | ---- |
| Cash outflows from financing activities | -59.10%15.16M | -74.12%9.28M | 45.30%4.8M | 320.85%51.71M | 381.75%37.06M | 498.37%35.86M | -9.53%3.3M | 1.36%12.29M | -21.96%7.69M | -25.39%5.99M |
| Net cash flows from financing activities | -105.76%-15.16M | -103.65%-9.28M | -101.67%-4.8M | 2,120.76%248.29M | 4,509.43%262.94M | 4,340.39%254.14M | 7,954.73%286.7M | -101.85%-12.29M | -100.94%-5.96M | -97.63%-5.99M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -100.02%-7.87 | -98.22%711.37 | -99.87%53.29 | -73.97%12.96K | 236.26%39.91K | -1.58%39.91K | --40.56K | 221.17%49.77K | 2.61%-29.29K | 234.63%40.55K |
| Net increase in cash and cash equivalents | 94.29%-15.16M | 64.45%-126.24M | 43.24%-46.92M | -142.09%-238.31M | -269.16%-265.69M | -215.36%-355.14M | 12.15%-82.67M | 303.54%566.15M | -49.15%157.06M | 217.69%307.84M |
| Add:Begin period cash and cash equivalents | -31.84%510.17M | -31.84%510.17M | -31.84%510.17M | 310.52%748.48M | 310.52%748.48M | 310.52%748.48M | 310.52%748.48M | -60.40%182.33M | -60.40%182.33M | -60.40%182.33M |
| End period cash equivalent | 2.53%495M | -2.39%383.92M | -30.42%463.24M | -31.84%510.17M | 42.26%482.79M | -19.75%393.34M | 654.71%665.81M | 310.52%748.48M | -55.89%339.38M | 146.44%490.16M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
